Aperture Tracker

Regions › United States › Healthcare & Life Sciences

US Healthcare & Life Sciences startup funding

US Healthcare & Life Sciences startups raised $10.4B across 257 funding rounds at 250 companies in the 12 months to Nov 14, 2026, against $11.4B across 331 rounds in the 12 months before (-9% in capital, -22% in rounds).

Companies headquartered in the United States, all funding stages, by announcement date. Data as of Nov 15, 2026; the last 12 months run Nov 15, 2025 – Nov 14, 2026. Capital counts disclosed amounts only (237 of 257 rounds in the last 12 months).

ExploreInteractive US view: Healthcare & Life Sciences →Healthcare & Life Sciences, North America, with sub-sector trends →Round-size benchmarks →

How much did US Healthcare & Life Sciences startups raise in the last 12 months?

Last 12 months against the 12 months before
Last 12 months12 months beforeChange
Capital raised (disclosed)$10.4B$11.4B-9%
Rounds257331-22%
Companies funded250311-20%

How much have US Healthcare & Life Sciences startups raised in 2026?

In 2026 through Nov 14, 2026, US Healthcare & Life Sciences startups raised $9.2B across 219 rounds, against $10.6B across 314 rounds in the same period of 2025.

Which US Healthcare & Life Sciences startups raised the most?

Chai Discovery raised the most in the last 12 months, 5% of the capital; the three largest companies together took 14%.

Companies that raised the most, last 12 months
CompanyCityCapital raisedRoundsLatest round
Chai DiscoverySan Francisco$530M2Series C · Jul 2026
OpenEvidenceMiami$500M2Stage not stated · Sep 2026
NewLimitSouth San Francisco$435M1Series C · Jun 2026
AbridgePittsburgh$316M1Series E · Jun 2026
EnvedaBoulder$311M1Series E · Sep 2026
VerilyDallas$300M1Stage not stated · Mar 2026
Function HealthAustin$298M1Series B · Nov 2025
Merge Labs—$252M1Seed · Jan 2026
Precision NeuroscienceNew York$250M1Series D · Sep 2026
Mirador TherapeuticsSan Diego$250M1Series B · Jan 2026

Which Healthcare & Life Sciences sub-sectors are growing in the US?

Drug discovery & protein design added the most companies: 30 raised in the 12 months before and 35 in the last 12 months.

Sub-sectors, last 12 months
Sub-sectorCompanies funded (year before → last 12 months)RoundsCapital raised
Care delivery & patient engagement67 → 6162$2.1B
Revenue cycle & healthcare admin67 → 5558$1.6B
Drug discovery & protein design30 → 3536$2.8B
Clinical trials & research operations13 → 1818$559M
Clinical decision support15 → 1213$680M
Medical imaging & diagnostics30 → 1111$523M
Consumer health & wellness12 → 1112$126M
Life-science research tools4 → 99$130M
Precision medicine & genomics12 → 88$615M
Health data & AI platforms14 → 88$95M
Clinical documentation16 → 77$471M
Pharma commercial & medical affairs3 → 55$170M
Brain-computer interfaces & neurotech7 → 44$563M
Medical robotics & devices7 → 22$16M
Quality, regulatory & safety5 → 22$7M

1 companies are not yet tagged with a sub-sector (Other / unclear).

How large is a typical US Healthcare & Life Sciences round?

In the last 12 months, the median disclosed Seed round was $5.8M, Series A round was $20M, Series B round was $44M.

Rounds by stage, last 12 months
StageRoundsWith a disclosed amountMedian disclosed round
Pre-Seed1515$2.1M
Seed7968$5.8M
Series A8380$20M
Series B3734$44M
Series C1212$90M
Series D66—
Series E66—
Series F+11—
Growth43—
Stage not stated1412$32M

Medians are shown where at least 10 amounts are disclosed.

US Healthcare & Life Sciences funding by quarter

Rounds and disclosed capital by announcement quarter
QuarterRoundsCapital raised
2025 Q153$3.1B
2025 Q285$3.1B
2025 Q394$2.4B
2025 Q4120$3.1B
2026 Q171$3.4B
2026 Q271$2.3B
2026 Q352$2.5B
2026 Q4 (to date)25$1B